Rani Therapeutics

Price & Volume

Stats

52W Range	$1.30-$8.75
Market Cap	$89.2M
Shares Short	1M

Financials

Revenue (12 Mos)	$0
Revenue Growth (YoY)	-100%
Gross Profit (12 Mos)	$2.7M
Diluted EPS	-$1.05

News

Yahoo Finance • last year

Rani Therapeutics Announces Strategic Program Prioritization, Expansion of Manufacturing and Plans to Streamline Business Operations to Support Near-Term Value Drivers and Long-Term Growth of the RaniPill® Technology Platform; Reports Preliminary Third Quarter 2023 Financial Results

Yahoo Finance • last year

The RaniPill® Capsule, Rani Therapeutics’ Oral Delivery Platform, was Well-Tolerated in 60-Day, Repeat-Administration, GLP Safety Study

Yahoo Finance • last year

Rani Therapeutics Announces Successful Oral Delivery of Monoclonal Antibody via High-Capacity Pill in Preclinical Study

Yahoo Finance • last year

Rani Therapeutics to Present Abstract on RT-102 at the 2023 Annual Meeting of the American Society for Bone and Mineral Research

About

CEO	Mr. Talat Imran
Address	2051 Ringwood Avenue, San Jose, CA, United States, 95131
Sector	Healthcare
Industry	Biotechnology
Full-Time Employees	140